What are ADC's

ADC 101
ADC Drug Map
Recommended Reading

Newsletter sign up

ADC Review
is made possible by:

ADC University

All you need to know about Antibody-Drug-Conjugates just a click away...

The Next Generation Pharmaceuticals
What Are Antibody-Drug Conjugates?
How do ADCs work
Monoclonal Antibodies
Stable Linker (Technologies)
- PEG Linkers
Cytotoxic Agents
Targeting Cancer with Antibody-drug Conjugates
Immunoglobulin G (IgG) antibody isotypes
Antibody Dependent Cell-Mediated Cytotoxicity
Glossary
Changing Strategies in the War on Cancer – 1
Characterization of Antibody-drug Conjugates
Clinical Trials
Can an ADC be Greater than the Sum of Its Parts?
Changing Strategies in the War on Cancer – 2
Changing Strategies in the War on Cancer – 3
Package Inserts -Antibody-drug Conjugates

Over the last decade, and after the approval of a number of antibody-drug conjugates, the field of ADCs has gained significant momentum. With ongoing research efforts, scientists have been successful in developing a great number of antibody-drug conjugates to treat a wide array of solid and liquid tumors.

The new Expert/Knowledge Center, which includes a new ADC drug map, is designed to offer a visual overview – linked to all relevant information – of all currently approved ADCs and ADCs in clinical development.

How to Contribute

Submit a Manuscript

Become a Contributor

Annual Resource Guide